Abbott Laboratories ( ABT ) recently announced that it is collaborating with Astellas Pharma Global Development for a phase III study being conducted with ASP0113 (TransVax). TransVax, a
Read the original post:
Abbott-Astellas Collaborate – Analyst Blog